Hypolipidemic agents.
D000085:Acetates / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D001393:Azoles / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D002784:Cholesterol / Q000096:biosynthesis / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003327:Coronary Disease / Q000453:epidemiology; D004032:Diet; D004285:Dogs; D004952:Esters / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D000882:Haplorhini; D006331:Heart Diseases / Q000401:mortality; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000037:antagonists & inhibitors* / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008798:Mevalonic Acid / Q000627:therapeutic use; D051379:Mice; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D010080:Oxazoles / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D051381:Rats; D013256:Steroids / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use
D000085:Acetates; D001393:Azoles; D002087:Butyrates; D004952:Esters; D004967:Estrogens; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D009539:Nicotinic Acids; D010080:Oxazoles; D011453:Prostaglandins; D011720:Pyrazoles; D011725:Pyridines; D013256:Steroids; D002792:Cholestyramine Resin; D002784:Cholesterol; D013974:Thyroxine; D008798:Mevalonic Acid